LIP
HAE icon

Lighthouse Investment Partners’s Haemonetics HAE Stock Holding History

Lighthouse Investment Partners’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,400
Closed -$1.23M – 457
2024
Q1 		$1.23M Buy
+14,400
New +$1.13M 0.06% 277

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lighthouse Investment Partners's HAE Position: Q2 2024 in Review

Lighthouse Investment Partners sold out of Haemonetics (HAE) in Q2 2024, closing a stake of 14,400 shares — an estimated $1.23M sold.

Lighthouse Investment Partners first reported a position in HAE in Q1 2024 and held it in 1 quarter. The position peaked at $1.23M in Q1 2024. 317 funds tracked by Wall St. Rank hold HAE as of Q2 2024.

  • Lighthouse Investment Partners reported no remaining Haemonetics position as of Q2 2024 after selling out during the quarter.
  • Lighthouse Investment Partners sold 14,400 Haemonetics shares in Q2 2024, an estimated $1.23M.
  • Lighthouse Investment Partners first reported a position in Haemonetics in Q1 2024 and held it in 1 quarter.
  • Lighthouse Investment Partners's Haemonetics position peaked at $1.23M in Q1 2024.
  • 317 funds tracked by Wall St. Rank held Haemonetics as of Q2 2024.

Based on Lighthouse Investment Partners's 13F filing for Q2 2024, filed 14 Aug 2024.